10 mai 2023
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2023.19.826.920
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/37162415
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_ED3E029934AE0
info:eu-repo/semantics/embargoedAccess , Restricted: cannot be viewed until 2024-11-10 , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
C. Charlier et al., « 5 minutes pour apprendre. Hallucination ne rime pas avec halopéridol [Haloperidol is not the first choice for every case of delirium] », Serveur académique Lausannois, ID : 10.53738/REVMED.2023.19.826.920
Haloperidol is frequently used as first-line treatment for delirium. The Swiss Smarter medicine campaign recommends to favor non-pharmacological interventions and treatment of the underlying causes, in order to limit the use of haloperidol. When antipsychotics are necessary, they should be prescribed cautiously, taking into account contraindications and potential side effects. This article emphasizes the importance of history taking in patient with delirium before prescribing haloperidol.